Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Trial of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women

NCT00611533 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00611533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00611533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Trial of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2004
Completion date
April 30, 2008
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive disturbances, menopause